United States
Germany
Japan
United Kingdom
China
CNY 5,973.00
5周
ERK2 (MAPK1) (C-term) (incl. pos. control) mouse monoclonal antibody, clone 6G11, Biotin
| Applications | ELISA, IP, WB |
| Reactivities | Canine, Human, Mouse, Rat |
Products
Transient overexpression lysate of mitogen-activated protein kinase 1 (MAPK1), transcript variant 2
| Tag | C-Myc/DDK |
| Expression Host | HEK293T |
CNY 5,973.00
5周
ERK2 (MAPK1) (N-term) (incl. pos. control) mouse monoclonal antibody, clone 6H3, Biotin
| Applications | ELISA, WB |
| Reactivities | Canine, Human, Mouse, Rat |
Anti-MAPK1 (ERK2) mouse monoclonal antibody, clone OTI1C11 (formerly 1C11)
| Applications | IP, WB |
| Reactivities | Human, Mouse, Rat |
ERK2 (MAPK1) (N-term) rabbit polyclonal antibody, Aff - Purified
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
活动过滤器
优化搜索结果
Species
Reactivities
Antibody Hosts
Expression Hosts
Tags
Knockout (KO) Validation
Conjugates
Modifications
Isotypes
Clonalities
Assay Types
Brands
Pathways
- Acute myeloid leukemia (65)
- Adherens junction (65)
- Alzheimer's disease (65)
- Axon guidance (65)
- B cell receptor signaling pathway (65)
- Bladder cancer (65)
- Chemokine signaling pathway (65)
- Chronic myeloid leukemia (65)
- Colorectal cancer (65)
- Dorso-ventral axis formation (65)
- Endometrial cancer (65)
- ErbB signaling pathway (65)
- Fc epsilon RI signaling pathway (65)
- Fc gamma R-mediated phagocytosis (65)
- Focal adhesion (65)
- Gap junction (65)
- Glioma (65)
- GnRH signaling pathway (65)
- Insulin signaling pathway (65)
- Long-term depression (65)
- Long-term potentiation (65)
- MAPK signaling pathway (65)
- Melanogenesis (65)
- Melanoma (65)
- NOD-like receptor signaling pathway (65)
- Natural killer cell mediated cytotoxicity (65)
- Neurotrophin signaling pathway (65)
- Non-small cell lung cancer (65)
- Oocyte meiosis (65)
- Pancreatic cancer (65)
- Pathways in cancer (65)
- Prion diseases (65)
- Progesterone-mediated oocyte maturation (65)
- Prostate cancer (65)
- Regulation of actin cytoskeleton (65)
- Renal cell carcinoma (65)
- T cell receptor signaling pathway (65)
- TGF-beta signaling pathway (65)
- Thyroid cancer (65)
- Toll-like receptor signaling pathway (65)
- Type II diabetes mellitus (65)
- VEGF signaling pathway (65)
- Vascular smooth muscle contraction (65)
- mTOR signaling pathway (65)
